WTF Are You Waiting ForJust another Site 1 Sites site

Elevated fat and cholesterol levels found in a typical American-style diet plays an important role in the growth and spread of prostate cancer, say researchers at Thomas Jefferson University’s Kimmel Cancer Center. Their study, the first to show such an association, is published in the December issue of The American Journal of Pathology…

Original post: High Dietary Fat, Cholesterol Linked To Increase Risk Of Prostate Cancer

Read the rest of this entry »

Researchers from the UC Davis Health System have found that compared with healthy controls, blood levels of vitamin D are significantly reduced in patients in the Sacramento area with metabolic syndrome, a constellation of disease risk factors that affects about one in three U.S. adults and predisposes them to diabetes, heart disease and stroke…

Original post: Low Vitamin-D Levels Found In Northern California Residents With Metabolic Syndrome

Read the rest of this entry »

China Pharma Holdings, Inc. (“China Pharma”) (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced the completion of clinical trials of the cholesterol-lowering drug, rosuvastatin (generic version of Crestor), which the Company intends to commercialize in the large and expanding Chinese healthcare market…

Original post: China Pharma Holdings, Inc. Announces Successful Completion Of Clinical Trials Of The Cholesterol-Lowering Drug, Rosuvastatin

Read the rest of this entry »

Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reduc…

Original post: Spherix Phase 2 Trial With D-tagatose Determines Minimum Dose For HbA1c And Triglycerides

Read the rest of this entry »

The Center for Connected Health, a division of Partners HealthCare, announced the appointment of Stephanie A. Moore, MD, as Medical Director for the Center’s Connected Cardiac Care program. Dr. Moore is a cardiologist specializing in heart failure at Massachusetts General Hospital Heart Center…

Original post: Mass General Cardiologist Brings Clinical Experience To Partners Connected Cardiac Care Program For High Risk Heart Failure Patients

Read the rest of this entry »